Lung Cancer Screening Software Market is Grow at a CAGR of 19.4% by 2029

Control of lung cancer death rates is one of the major concerns for healthcare facilities. Public and private organizations are taking initiatives to launch screening programs to control the death rates. In addition, companies are launching advanced software to ease the management of patients' data and provide better care with strict data privacy guidelines.

Increase in prevalence of lung cancer, rising awareness among people about lung cancer, increasing government initiatives and growing number of screening programs are some of the major factors driving the growth of the market. In addition, advancement in Artificial Intelligence (AI)-based solutions and strategic initiatives by key market players are creating opportunities in the field of lung cancer screening software.

However, data privacy issues and lack of unskilled labor are expected to hamper the market growth in the forecast period.

Data Bridge Market Research analyzes that the global lung cancer screening software market is expected to reach the value of USD 115,027.61 thousand by 2029, at a CAGR of 19.4% during the forecast period. Cloud based solutions accounts for largest mode of delivery segment in the market. The market report also covers pricing analysis, patent analysis and technological advancements in depth

Access Full report: https://www.databridgemarketresearch.com/reports/global-lung-cancer-screening-software-market

Market Definition

Lung cancer screening is identifying stages of lung cancer using different technologies and software. Lung cancer screening using CT is the most recommended technique for screening lung cancer. The rising use of this technique is expected to accelerate the need for advanced software for lung cancer screening. This software helps to manage patients' participation in lung screening programs and provides an efficient way for healthcare professionals to collect, curate and transfer data to clinicians and patients. In addition, this software enables in the identification of patients at risk and automates the flow of data with integrated electronic health records.

Global Lung Cancer Screening Software Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints and challenges. All of this is discussed in detail below:

Drivers

Increase in prevalence of lung cancer cases globally
Lung cancer is a leading cause of death in men and women. According to World Cancer Research Fund International, lung cancer is the second most common cancer worldwide. It is the most common cancer in men and second most common in women. There were more than 2.2 thousand new cases of lung cancer in 2020. Increasing prevalence of lung cancer cases creates need to adopt lung cancer screening software for early diagnosis and thus, acts as a driving factor for the market growth.

Increase in awareness regarding the benefits of early diagnosis and frequent screening
The rising awareness programs of lung cancer by public, non-profit and private organizations are anticipated to boost the market growth. These initiatives aim to prevent diseases, reduce stigma and prejudice and promote research. The awareness among the population regarding lung cancer has increased. Because there are many awareness programs by different organizations, people know about lung cancer that can be cured if diagnosed early. Thus, raising awareness among populations is driving the market growth.

Government initiatives were undertaken to implement screening programs for various diseases
The burden of cancer continues to increase globally and has great financial, emotional and physical stress on health systems, products, families and individuals. In countries with strong health systems, the survival rate of many types of cancer is improved due to survivorship, quality care, increased awareness and accessible early detection. Centers for Disease Control and Prevention, U.S., tribes and the U.S.-Pacific islands and territories through the National Comprehensive Cancer Control Program (NCCCP) are to form or support alliances to combat cancer in their communities. Due to these initiatives, more audiences are educated and more consciously dispersed, pushing the global audience to take further precautions and practice preventive examinations, promoting the market.

Growing number of screening programs across the globe
Screening is an effective method of detecting early-stage cancer. There is an increasing trend in lung cancer incidences in developing countries. Although there are regular recommendations for screening for breast and cervical cancer, it is not the same in case of lung cancer. Most countries or institutions have initiated the feasibility and disease screening of Low-Dose Computed Tomography (LDCT) for lung cancer. The increasing number of lung cancer screening has created an opportunity for the market players. Hence, the increasing diagnostic rate acts as a driving factor for market growth.

GET A PDF SAMPLE: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lung-cancer-screening-software-market

Global Lung Cancer Screening Software Market Scope
The global lung cancer screening software market is segmented into eight notable segments based on mode of delivery, product, type, application, platform, purchase mode, end user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Mode of Delivery

Cloud Based Solutions
On-Premise Solutions
Web Based Solutions
On the basis of mode of delivery, the market is segmented into cloud based solutions, on-premise solutions and web based solutions.

Product

Lung Cancer Screening Radiology Solution
Lung Cancer Screening Patient Management Software
Nodule Management Software
Data Collection and Reporting
Patient Coordination and Workflow
Lung Nodule Computer Aided Detection
Pathology and Cancer Staging
Statistical Audit Reporting
Screening PACS
Practice Management
Audit Log Tracking
On the basis of product, the market is segmented into lung cancer screening radiology solution, lung cancer screening patient management software, nodule management software, data collection and reporting, patient coordination and workflow, lung nodule computer aided detection, pathology and cancer staging, statistical audit reporting, screening PACS, practice management and audit log tracking.

Type

Computer-Assisted Screening
Traditional Screening
On the basis of type, the market is segmented into computer-assisted screening and traditional screening.

Application

Non-Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer (SCLC)
On the basis of application, the market is segmented into Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).

Platform

Standalone
Integrated
On the basis of platform, the market is segmented into standalone and integrated.

Purchase Mode

Institutional
Individual
On the basis of purchase mode, the market is segmented into individual and institutional.

End User

Oncology Centers
Hospitals
Ambulatory Surgical Centers
Others

Browse More Reports:

https://www.blogger.com/blog/post/preview/2488328241346209773/7797348821819043373

https://dbmrbuisness.blogspot.com/2023/11/europe-lung-cancer-screening-software.html

https://dbmrbuisness.blogspot.com/2023/11/north-america-lung-cancer-screening.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.